← Back to Search

Genomic Sequencing for Pregnancy

N/A

Recruiting

Led By Mary Norton, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Planning to undergo prenatal diagnosis by either chorionic villus sampling or amniocentesis with chromosome microarray analysis for routine indications

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 2 months after enrollment

Awards & highlights

Study Summary

This trial will look at how useful genomic sequencing is for patients who are having prenatal diagnostic procedures for regular reasons, not because there is a problem with the baby's structure.

Who is the study for?

This clinical trial is for pregnant individuals undergoing routine prenatal diagnostic procedures like chorionic villus sampling or amniocentesis, but not because of a structural fetal anomaly. The study will include those who meet the specific conditions set by the researchers.Check my eligibility

What is being tested?

The trial is studying genomic sequencing (GS) to see how useful it is in understanding health information about fetuses that appear normal on anatomy scans during pregnancy.See study design

What are the potential side effects?

Since this study involves genomic sequencing, there are no direct physical side effects from the intervention itself. However, standard risks associated with prenatal testing procedures apply.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I plan to have prenatal tests (CVS or amniocentesis) with detailed chromosome analysis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 2 months after enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 2 months after enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 months after enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Detection of pathogenic or likely pathogenic variants with genomic sequencing

Trial Design

1Treatment groups

Experimental Treatment

Group I: Genomic SequencingExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,507 Previous Clinical Trials

15,237,575 Total Patients Enrolled

Mary Norton, MDPrincipal InvestigatorUniversity of California, San Francisco

6 Previous Clinical Trials

22,841 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the specific criteria for individuals to qualify as participants in this research project?

"In order to be eligible for enrollment in this investigation, prospective participants must undergo prenatal evaluations and be between the ages of 18 and 64. The clinical trial has capacity for a total of 1000 individuals."

Answered by AI

Are patients currently eligible to participate in this ongoing medical study?

"The information available on clinicaltrials.gov indicates that the recruitment phase for this particular clinical trial has concluded. The trial was initially posted on 1/1/2024 and last updated on 1/8/2024. However, it is important to note that there are currently other ongoing clinical trials actively seeking participants, with one being conducted simultaneously."

Answered by AI